F Zeni Selected Research

Shock

12/2009

Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Zeni Research Topics

Disease

1	Transfusion Reaction 05/2018
1	Critical Illness (Critically Ill) 01/2010
1	Hemorrhage 12/2009
1	Pulmonary Embolism 12/2009
1	Shock 12/2009
1	Neoplasms (Cancer) 11/2002
1	Peritonitis 08/2000
1	Sepsis (Septicemia) 05/2000
1	Septic Shock (Toxic Shock Syndrome) 05/2000
1	Infections 05/2000

Drug/Important Bio-Agent (IBA)

1	BESIBA 05/2018
1	Vancomycin FDA LinkGeneric 01/2010
1	Heparin (Liquaemin)FDA LinkGeneric 12/2009
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2009
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2009
1	Interleukin-6 (Interleukin 6)IBA 08/2000
1	CytokinesIBA 08/2000
1	ProcalcitoninIBA 08/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2000
1	EndotoxinsIBA 05/2000

Therapy/Procedure

2	Therapeutics 05/2018 - 11/2002
1	Artificial Respiration (Mechanical Ventilation) 05/2000